Literature DB >> 1700695

Kinetics of the inhibition of human pancreatic elastase by recombinant eglin c. Influence of elastin.

B Faller1, S Dirrig, M Rabaud, J G Bieth.   

Abstract

Recombinant eglin c is a potent reversible inhibitor of human pancreatic elastase. At pH 7.4 and 25 degrees C, kass. = 7.3 x 10(5) M-1.s-1, kdiss. = 2.7 x 10(-4) s-1 and Ki = 3.7 x 10(-10) M. Stopped-flow kinetic indicate that the formation of the stable enzyme-inhibitor complex is not preceded by a fast pre-equilibrium complex or that the latter has a dissociation constant greater than 0.3 microM. The elastase-eglin c complex is much less stable at pH 5.0 and 25 degrees C, where kdiss. = 1.1 x 10(-2) s-1 and Ki = 7.3 x 10(-8) M. At pH 7.4 the activation energy for kass. is 43.9 kJ.mol-1 (10.5 kcal.mol-1). The kass. increases between pH 5.0 and 8.0 and remains essentially constant up to pH 9.0. This pH-dependence could not be described by a simple ionization curve. Both alpha 2-macroglobulin and alpha 1-proteinase inhibitor are able to dissociate the elastase-eglin c complex, as evidenced by measurement of the enzymic activity of alpha 2-macroglobulin-bound elastase or by polyacrylamide-gel electrophoresis of mixtures of alpha 1-proteinase inhibitor and elastase-eglin c complex. The rough estimate of kdiss. obtained with the alpha 2-macroglobulin dissociation experiment (1.6 x 10(-4) s-1) was of the same order of magnitude as the constant measured with the progress curve method. Eglin c strongly inhibits the solubilization of human aorta elastin by human pancreatic elastase. The extent of inhibition is the same whether elastase is added to a suspension of elastin and eglin c or whether elastase is preincubated with elastin for 3 min before addition of eglin c. However, the efficiency of the inhibitor sharply decreases if elastase is reacted with elastin for more prolonged periods.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1700695      PMCID: PMC1131779          DOI: 10.1042/bj2700639

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  28 in total

Review 1.  MECHANISM OF ACTION OF PROTEOLYTIC ENZYMES.

Authors:  M L BENDER; J KEZDY
Journal:  Annu Rev Biochem       Date:  1965       Impact factor: 23.643

2.  Tight-binding inhibitors-I. Kinetic behavior.

Authors:  S Cha
Journal:  Biochem Pharmacol       Date:  1975-12-01       Impact factor: 5.858

3.  Kinetic evidence for a two-step mechanism for the binding of chymotrypsin to alpha 1-proteinase inhibitor.

Authors:  M Bruch; J G Bieth
Journal:  Biochem J       Date:  1989-05-01       Impact factor: 3.857

4.  Kinetic studies on the interaction of eglin c with human leukocyte elastase and cathepsin G.

Authors:  N J Braun; J L Bodmer; G D Virca; G Metz-Virca; R Maschler; J G Bieth; H P Schnebli
Journal:  Biol Chem Hoppe Seyler       Date:  1987-04

5.  Inhibition of free and elastin-bound human pancreatic elastase by human bronchial inhibitor.

Authors:  P Laurent; M Rabaud; J G Bieth
Journal:  Biochem Pharmacol       Date:  1987-03-01       Impact factor: 5.858

6.  Inhibition of mast cell chymase by eglin c and antileukoprotease (HUSI-I). Indications for potential biological functions of these inhibitors.

Authors:  E Fink; R Nettelbeck; H Fritz
Journal:  Biol Chem Hoppe Seyler       Date:  1986-07

7.  The high-resolution X-ray crystal structure of the complex formed between subtilisin Carlsberg and eglin c, an elastase inhibitor from the leech Hirudo medicinalis. Structural analysis, subtilisin structure and interface geometry.

Authors:  W Bode; E Papamokos; D Musil
Journal:  Eur J Biochem       Date:  1987-08-03

8.  Pulmonary vascular injury in pancreatitis: evidence for a major role played by pancreatic elastase.

Authors:  G Lungarella; C Gardi; M M de Santi; P Luzi
Journal:  Exp Mol Pathol       Date:  1985-02       Impact factor: 3.362

9.  Primary structure of human pancreatic elastase 2 determined by sequence analysis of the cloned mRNA.

Authors:  T S Fletcher; W F Shen; C Largman
Journal:  Biochemistry       Date:  1987-11-17       Impact factor: 3.162

10.  Influence of elastin on the inhibition of leucocyte elastase by alpha 1-proteinase inhibitor and bronchial inhibitor. Potent inhibition of elastin-bound elastase by bronchial inhibitor.

Authors:  M Bruch; J G Bieth
Journal:  Biochem J       Date:  1986-08-15       Impact factor: 3.857

View more
  2 in total

1.  Kinetics of the interaction of chymotrypsin with eglin c.

Authors:  B Faller; J G Bieth
Journal:  Biochem J       Date:  1991-11-15       Impact factor: 3.857

2.  Inhibition of human pancreatic proteinases by mucus proteinase inhibitor, eglin c and aprotinin.

Authors:  D Belorgey; S Dirrig; M Amouric; C Figarella; J G Bieth
Journal:  Biochem J       Date:  1996-01-15       Impact factor: 3.857

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.